The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice
Open accessAbstract
Background: Dietary intake of fruit and vegetables is associated with lower incidence of hypertension, but the mechanisms involved have not been elucidated. Here, we evaluated the effect of a high-fiber diet and supplementation with the short-chain fatty acid acetate on the gut microbiota and the prevention of cardiovascular disease. Methods: Gut microbiome, cardiorenal structure/function, and blood pressure were examined in sham and mineralocorticoid excess–treated mice with a control diet, high-fiber diet, or acetate supplementation. We also determined the renal and cardiac transcriptome of mice treated with the different diets. Results: We found that high consumption of fiber modified the gut microbiota populations and increased the abundance of acetate-producing bacteria independently of mineralocorticoid excess. Both fiber and acetate decreased gut dysbiosis, measured by the ratio of Firmicutes to Bacteroidetes, and increased the prevalence of Bacteroides acidifaciens . Compared with mineralocorticoid-excess mice fed a control diet, both high-fiber diet and acetate supplementation significantly reduced systolic and diastolic blood pressures, cardiac fibrosis, and left ventricular hypertrophy. Acetate had similar effects and markedly reduced renal fibrosis. Transcriptome analyses showed that the protective effects of high fiber and acetate were accompanied by the downregulation of cardiac and renal Egr1 , a master cardiovascular regulator involved in cardiac hypertrophy, cardiorenal fibrosis, and inflammation. We also observed the upregulation of a network of genes involved in circadian rhythm in both tissues and downregulation of the renin-angiotensin system in the kidney and mitogen-activated protein kinase signaling in the heart. Conclusions: A diet high in fiber led to changes in the gut microbiota that played a protective role in the development of cardiovascular disease. The favorable effects of fiber may be explained by the generation and distribution of one of the main metabolites of the gut microbiota, the short-chain fatty acid acetate. Acetate effected several molecular changes associated with improved cardiovascular health and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One example includes a recent rodent hypertension study in which either a high-fiber diet (a prebiotic) or acetic acid alone (a gut microbial product) resulted in reduced blood pressure and adverse cardiac remodeling168.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [168]
In the citing paper
“A significant proportion of the SCFAs produced in the distal bowel is reabsorbed from the gut lumen by facilitated apical solute transport via multiple different transporters114–117 as well as via passive (concentration-dependent) diffusion118.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [118]
In the citing paper
“Finally, studies in animal models and in patients with hypertension have reported that interventions that target the gut microbiota, such as a high-fibre diet, probiotics and antibiotics, have blood-pressure lowering effects87,92–99.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [95]
In the citing paper
“In DOCA-salt hypertensive mice, a high-fibre diet led to substantial reductions in both SBP and DBP (~20 mmHg)95.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedSubramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1038/mi.2016.1042 · DOI
Cited by
Sorted by citations
Items 301–400 of 998
Wang, A. Y.-M., Sea, M. M.-M., Ng, K., Wang, M., Chan, I. H.-S., Lam, C. W.-K., Sanderson, J. E., & Woo, J. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.03.007 · Cited by 43
Ting, C.-H., Pan, C., Chen, Y.-C., Lin, Y.-C., Chen, T.-Y., Rajanbabu, V., & Chen, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-55509-9 · Cited by 43
Mu, F., Tang, M., Guan, Y., Lin, R., Zhao, M., Zhao, J., Huang, S., Zhang, H., Wang, J., & Tang, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.882660 · Cited by 42
Yang, F., Xia, N., Guo, S., Zhang, J., Liao, Y., Tang, T., Nie, S., Zhang, M., Lv, B., Lu, Y., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.05.001 · Cited by 44
Zambrano, A. K., Cadena-Ullauri, S., Ruiz‐Pozo, V. A., Tamayo‐Trujillo, R., Paz‐Cruz, E., Guevara‐Ramírez, P., Frías-Toral, E., & Simancas‐Racines, D. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05175-x · Cited by 45
The gut–immune axis during hypertension and cardiovascular diseases
Dinakis, E., O’Donnell, J. A., & Marques, F. Z. (2024) · Acta Physiologica · doi:10.1111/apha.14193 · Cited by 49
Self-citationYoshida, N., Sasaki, K., Sasaki, D., Yamashita, T., Fukuda, H., Hayashi, T., Tabata, T., Osawa, R., Hirata, K., & Kondo, A. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.47415 · Cited by 42
Steinke, I., Ghanei, N., Govindarajulu, M., Yoo, S., Zhong, J., & Amin, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.567899 · Cited by 44
Qu, L., Dong, Z.-Y., Ma, S., Liu, Y., Zhou, W., Wang, Z., Wu, C., Ma, R., Jiang, X., Zu, T., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.841614 · Cited by 41
Effects of gut microbiota on atherosclerosis through hydrogen sulfide
Gui, D.-D., Luo, W., Yan, B., Ren, Z., Tang, Z., Liu, L.-S., Zhang, J., & Jiang, Z.-S. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173916 · Cited by 40
Qi, Y., Kim, S., Richards, E. M., Raizada, M. K., & Pepine, C. J. (2017) · Circulation Research · doi:10.1161/circresaha.117.310734 · Cited by 41
Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
Belli, M., Barone, L., Longo, S., Prandi, F. R., Lecis, D., Mollace, R., Margonato, D., Muscoli, S., Sergi, D., Federici, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511971 · Cited by 43
eRNAbase: a comprehensive database for decoding the regulatory eRNAs in human and mouse
Song, C., Zhang, G., Mu, X., Feng, C., Zhang, Q., Song, S., Zhang, Y., Yin, M., Zhang, H., Tang, H., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad925 · Cited by 40
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation
Shi, B., Li, H., & He, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2323237 · Cited by 43
What is the best diet for cardiovascular wellness? A comparison of different nutritional models
Migliaccio, S., Brasacchio, C., Pivari, F., Salzano, C., Barrea, L., Muscogiuri, G., Savastano, S., Colao, A., & on behalf of Obesity Programs of nutrition, E. (2020) · International Journal of Obesity Supplements · doi:10.1038/s41367-020-0018-0 · Cited by 39
Lv, J., Wang, J., Yu, Y., Zhao, M., Yang, W., Liu, J., Zhao, Y., Yang, Y., Wang, G., Guo, L., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04176-6 · Cited by 44
Tang, Z., Yu, S., & Pan, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04455-2 · Cited by 42
Hsu, C., & Tain, Y. (2018) · Nutrients · doi:10.3390/nu10121917 · Cited by 39
Quality of plant-based diets and risk of hypertension: a Korean genome and examination study
Kim, J., Kim, H., & Giovannucci, E. L. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02559-3 · Cited by 40
Zhang, C., Chen, F., Shen, Y., Chen, Y., & Ma, J. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2147509 · Cited by 39
Targeting metabolism in aortic aneurysm and dissection: from basic research to clinical applications
Wang, Q., Yesitayi, G., Liu, B., Siti, D., Ainiwan, M., Aizitiaili, A., & Ma, X. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85467 · Cited by 43
Flori, L., Benedetti, G., Martelli, A., & Calderone, V. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107334 · Cited by 40
Endocrine organs of cardiovascular diseases: Gut microbiota
Jia, Q., Xie, Y., Lu, C., Zhang, A., Lu, Y., Lv, S., & Zhang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14164 · Cited by 38
The gut microbiota and diabetic cardiomyopathy in humans
Bastin, M., & Andréelli, F. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.10.003 · Cited by 38
Chen, H., Wang, M., Chen, Y., Chen, L., Wang, Y., Vaziri, N. D., Miao, H., & Zhao, Y. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320920025 · Cited by 38
Novel mechanisms of salt-sensitive hypertension
Vogt, L., Marques, F. Z., Fujita, T., Hoorn, E. J., & Danser, A. H. J. (2023) · Kidney International · doi:10.1016/j.kint.2023.06.035 · Cited by 36
Self-citationPolsinelli, V. B., Marteau, L., & Shah, S. J. (2019) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000414 · Cited by 37
Gut Microbiota and Cardiovascular Diseases
Anselmi, G., Gagliardi, L., Egidi, G., Leone, S., Gasbarrini, A., Miggiano, G. A. D., & Galiuto, L. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000327 · Cited by 37
Park, G. S. H., Jung, S., Wellen, K. E., & Jang, C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00614-x · Cited by 37
Hypertension and the Gut Microbiome: A Science Advisory From the American Heart Association
Yang, T., Maki, K. A., Marques, F. Z., Cai, J., Joe, B., Pepine, C. J., Pluznick, J. L., Meyer, K. A., Kirabo, A., & Bennett, B. J. (2025) · Hypertension · doi:10.1161/hyp.0000000000000247 · Cited by 42
Self-citationImbalance of gut microbiome and intestinal epithelial barrier dysfunction in cardiovascular disease
Lezutekong, J. N., Nikhanj, A., & Oudit, G. Y. (2018) · Clinical Science · doi:10.1042/cs20180172 · Cited by 38
Sotomayor, C. G., Neto, A. W. G., Eisenga, M. F., Nolte, I. M., Anderson, J. L. C., de Borst, M. H., Osté, M. C. J., Rodrigo, R., Gans, R. O. B., Berger, S. P., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy248 · Cited by 36
The gut microbiome and heart failure
Ahmad, A. F., Ward, N. C., & Dwivedi, G. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000598 · Cited by 35
Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension
Sigmund, C. D., Carey, R. M., Appel, L. J., Arnett, D. K., Bosworth, H. B., Cushman, W. C., Galis, Z. S., Parker, M. G., Hall, J. E., Harrison, D. G., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13887 · Cited by 37
Gao, G., Cao, J., Mi, L., Feng, D., Deng, Q., Sun, X.-B., Zhang, H., Wang, Q., & Wang, J. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.172 · Cited by 35
Zhao, J., Cheng, W., Lu, H., Shan, A., Zhang, Q., Sun, X., Kang, L., Xie, J., & Xu, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1046912 · Cited by 36
Gut dysbiosis and metabolic diseases
Bandopadhyay, P., & Ganguly, D. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.031 · Cited by 42
Identification of Gut Microbiota Affecting Fiber Digestibility in Pigs
Niu, Q., Pu, G., Fan, L., Chen, G., Lan, T., Liu, C., Du, T., Kim, S. W., Niu, P., Zhang, Z., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100312 · Cited by 34
Inflammatory Response: A Crucial Way for Gut Microbes to Regulate Cardiovascular Diseases
Wang, W., Zhu, L., Leng, Y.-Q., Wang, Y.-W., Shi, T., Wang, W., & Sun, J. (2023) · Nutrients · doi:10.3390/nu15030607 · Cited by 35
Cacabelos, R., Carril, J. C., Sanmartín, A., & Cacabelos, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00006-1 · Cited by 36
Gut microbiome and cardiometabolic risk
Kappel, B. A., & Federici, M. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09533-9 · Cited by 36
The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure
Sata, Y., Marques, F. Z., & Kaye, D. M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01046-0 · Cited by 34
Self-citationSugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis
Cheng, W., Li, S., Lee, T.-I., Lee, T., Chung, C., Kao, Y., & Chen, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9070728 · Cited by 41
Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs
Zhan, S., Li, N., Liu, C., Mao, R., Wu, D., Li, T., Chen, M., Zhuang, X., & Zeng, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.694967 · Cited by 35
Han, Z., Chen, M., Fu, X., Yang, M., Hrmová, M., Zhao, Y., & Mou, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189823 · Cited by 37
Yang, C., Wan, M., Xu, D., Pan, D., Xia, H., Yang, L., & Sun, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910858 · Cited by 35
Challa, A. A., & Lewandowski, E. D. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.12.010 · Cited by 35
Zhu, Y., & Wang, Z. (2024) · BMC Public Health · doi:10.1186/s12889-024-18346-8 · Cited by 44
The role of diet-derived short-chain fatty acids in regulating cardiac pressure overload
Pakhomov, N. V., & Baugh, J. A. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00573.2020 · Cited by 34
The Impact of Migration on the Gut Metagenome of South Asian Canadians
Copeland, J. K., Chao, G. Y. C., Vanderhout, S. M., Acton, E., Wang, P. W., Benchimol, E. I., El‐Sohemy, A., Croitoru, K., Gommerman, J. L., Guttman, D. S., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1902705 · Cited by 34
Li, C., Zhou, W., Li, M., Shu, X., Zhang, L. R., & Ji, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111587 · Cited by 35
Gut Microbiota and Environment in Coronary Artery Disease
Piccioni, A., de Cunzo, T., Valletta, F., Covino, M., Rinninella, E., Raoul, P. C., Zanza, C., Mele, M. C., & Franceschi, F. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084242 · Cited by 34
Bacterial-Induced Blood Pressure Reduction: Mechanisms for the Treatment of Hypertension via the Gut
Cookson, T. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.721393 · Cited by 36
The Role of Gut Microbiota in Hypertension Pathogenesis and the Efficacy of Antihypertensive Drugs
Xiong, Y., Xiong, Y., Zhu, P., Wang, Y., Yang, H., Zhou, R., Shu, Y., Zhou, H., & Li, Q. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01157-2 · Cited by 35
Wu, H., Lam, T. Y. C., Shum, T., Tsai, T., & Chiou, J. A. (2021) · Hypertension Research · doi:10.1038/s41440-021-00796-x · Cited by 34
The Gut in Heart Failure: Current Knowledge and Novel Frontiers
Gallo, A., Macerola, N., Favuzzi, A. M. R., Nicolazzi, M. A., Gasbarrini, A., & Montalto, M. (2022) · Medical Principles and Practice · doi:10.1159/000522284 · Cited by 36
Pasdar, Y., Hamzeh, B., Moradi, S., Mohammadi, E., Cheshmeh, S., Darbandi, M., Safari‐Faramani, R., & Najafi, F. (2022) · BMC Public Health · doi:10.1186/s12889-022-13166-0 · Cited by 37
The Gut Microbiota and Vascular Aging: A State-of-the-Art and Systematic Review of the Literature
Agnoletti, D., Piani, F., Cicero, A. F. G., & Borghi, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123557 · Cited by 37
Resistance to Antihypertensive Drugs: Is Gut Microbiota the Missing Link?
Kyoung, J., Atluri, R., & Yang, T. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19826 · Cited by 35
Washed microbiota transplantation improves patients with metabolic syndrome in South China
Wu, L., Lu, X., Lin, D.-J., Chen, W.-J., Xue, X.-Y., Liu, T., Xu, J., Xie, Y.-T., Li, M.-Q., Lin, W.-Y., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1044957 · Cited by 34
Gut microbiota and myocardial fibrosis
Han, X., Yang, F., & Bao, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175355 · Cited by 35
Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites
Chakraborty, S., Lulla, A., Cheng, X., Yeo, J., Mandal, J., Yang, T., Mei, X., Saha, P., Golonka, R. M., Yeoh, B. S., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003423 · Cited by 34
Bouillon, A., Ferreira, M. S. V., Awad, S. A., Richter, J., Hochhaus, A., Kunzmann, V., Dengler, J. B., Janssen, J. J. W. M., Ossenkoppele, G. J., Westerweel, P. E., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018017772 · Cited by 32
Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate
Prow, N. A., Hirata, T. D. C., Tang, B., Larcher, T., Mukhopadhyay, P., Alves, T. L., Le, T. T., Gardner, J., Poo, Y. S., Nakayama, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02736 · Cited by 32
Targeting the gut microbiota by Asian and Western dietary constituents: a new avenue for diabetes
Conteh, A. R., & Huang, R. (2020) · Toxicology Research · doi:10.1093/toxres/tfaa065 · Cited by 34
Fan, L., Ren, J., Chen, Y., Wang, Y., Guo, Z., Bu, P., Yang, J., Ma, W., Zhu, B., Zhao, Y., et al. (2022) · Trials · doi:10.1186/s13063-022-06086-2 · Cited by 34
Effects of Probiotics on Patients with Hypertension: a Systematic Review and Meta-Analysis
Chi, C., Li, C., Wu, D., Buys, N. J., Wang, W., Fan, H., & Sun, J. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01042-4 · Cited by 33
Positive Regulation of Acetate in Adipocyte Differentiation and Lipid Deposition in Obese Mice
Sun, C., Li, A., Wang, H., Ma, J., & Hou, J. (2023) · Nutrients · doi:10.3390/nu15173736 · Cited by 35
Song, Y., Wei, H., Zhou, Z., Wang, H., Hang, W., Wu, J., & Wang, D. W. (2024) · Frontiers of Medicine · doi:10.1007/s11684-024-1055-9 · Cited by 38
The Role of Gut Microbiota in the Etiopathogenesis of Multiple Chronic Diseases
Pires, L., Gonzaléz‐Paramás, A. M., Heleno, S. A., & Calhelha, R. C. (2024) · Antibiotics · doi:10.3390/antibiotics13050392 · Cited by 33
Pham, Q. H., Bui, T. V. A., Sim, W., Lim, K. H., Law, C. O. K., Tan, W., Kim, R. Y., Chow, K. T., Park, H., Ban, K., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae128 · Cited by 32
Role of gut microbiota and derived metabolites in cardiovascular diseases
Yu, J., Yang, Y., Chen, W., Hu, J., Jin, Z., Wu, C., & Li, Y. (2025) · iScience · doi:10.1016/j.isci.2025.113247 · Cited by 37
Gastrointestinal–Renal Axis: Role in the Regulation of Blood Pressure
Yang, J., José, P. A., & Zeng, C. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005536 · Cited by 33
Kashino, I., Eguchi, M., Miki, T., Kochi, T., Nanri, A., Kabe, I., & Mizoue, T. (2020) · Nutrients · doi:10.3390/nu12040902 · Cited by 32
Wang, J., Yang, M., Wu, Q., Chen, J., Deng, S.-F., Chen, L., Wei, D., & Liang, F. (2021) · Chinese Medicine · doi:10.1186/s13020-020-00417-8 · Cited by 34
The influence of gut microbiota in cardiovascular diseases—a brief review
Almeida, C., Barata, P., & Fernandes, R. (2021) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000106 · Cited by 35
Untapped potential of gut microbiome for hypertension management
Gao, K., Wang, P., Mei, X., Yang, T., & Yu, K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2356278 · Cited by 35
Renal damage in the metabolic syndrome (MetSx): Disorders implicated
Joyce, T., Chirino, Y. I., Martínez‐Tagüeña, N., & Pedraza‐Chaverrí, J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.032 · Cited by 30
Organ transplantation and gut microbiota: current reviews and future challenges.
Xiao, J., Peng, Z., Liao, Y., Sun, H., Chen, W., Chen, X., Wei, Z., Yang, C., Nussler, A. K., Liu, J., et al. (2018) · Europe PMC (PubMed Central) · Cited by 31
Mompeó, O., Spector, T. D., Matey-Hernandez, M. L., Roy, C. I. L., Istas, G., Sayec, M. L., Mangino, M., Jennings, A., Rodriguez‐Mateos, A., Valdes, A. M., et al. (2020) · Nutrients · doi:10.3390/nu12061871 · Cited by 32
Li, L., Wang, Y., Yuan, J., Liu, Z., Ye, C., & Qin, S. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10954-9 · Cited by 32
Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases
Wang, K., Dong, Y., Liu, J., Qian, L., Wang, T., Gao, X., Wang, K., & Zhou, L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5860356 · Cited by 34
The Gut Microbiome and Cardiovascular Disease
Astudillo, A., & MAYROVITZ, H. N. (2021) · Cureus · doi:10.7759/cureus.14519 · Cited by 32
Bai, H., Gu, R., Chen, L.-Y., Qian, Y., Yu, M., Xu, S.-L., Xia, X., Liu, Y.-C., Zhang, H., Gu, Y.-H., et al. (2021) · Microvascular Research · doi:10.1016/j.mvr.2021.104235 · Cited by 30
Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases
Panyod, S., Wu, W.-K., Chen, C., Wu, M., Ho, C., & Sheen, L. (2021) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2021.09.006 · Cited by 32
Polyphenols–Gut–Heart: An Impactful Relationship to Improve Cardiovascular Diseases
Bianchi, F., Cappella, A., Gagliano, N., Sfondrini, L., & Stacchiotti, A. (2022) · Antioxidants · doi:10.3390/antiox11091700 · Cited by 35
Intestinal microbiota: A promising therapeutic target for hypertension
Sun, D., Xiang, H., Yan, J., & He, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.970036 · Cited by 30
González‐Correa, C., Moleón, J., Miñano, S., Robles‐Vera, I., Toral, M., Martín‐Morales, N., O’Valle, F., Sánchez, M., Gómez‐Guzmán, M., Jiménez, R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114149 · Cited by 33
Duan, H., Li, J., & Fan, L. (2023) · Foods · doi:10.3390/foods12020424 · Cited by 31
Destructive Role of TMAO in T-Tubule and Excitation-Contraction Coupling in the Adult Cardiomyocytes
Jin, B., Ji, F., Zuo, A., Liu, H., Qi, L., He, Y., Wang, Q., & Zhao, P. (2020) · International Heart Journal · doi:10.1536/ihj.19-372 · Cited by 30
Gut macrobiotic and its metabolic pathways modulate cardiovascular disease
Zhu, J., Lyu, J., Zhao, R., Liu, G., & Wang, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1272479 · Cited by 31
Han, X., Fu, Y., Wang, K., Li, S., Jiang, C., Wang, S., Wang, Z., Liu, G., & Hu, S. (2023) · Food & Function · doi:10.1039/d3fo03233g · Cited by 30
Yin, X., Duan, C., Zhang, L., Zhu, Y., Qiu, Y., Shi, K., Wang, S., Zhang, X., Zhang, H., Hao, Y., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03061-3 · Cited by 33
Short-Chain Fatty Acids and Their Metabolic Interactions in Heart Failure
Chulenbayeva, L., Issilbayeva, A., Sailybayeva, A., Bekbossynova, M. S., Kozhakhmetov, S., & Kushugulova, A. R. (2025) · Biomedicines · doi:10.3390/biomedicines13020343 · Cited by 34
Key Insights into Gut Alterations in Metabolic Syndrome
Boicean, A., Ichim, C., Sasu, S.-M., & Todor, S. B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082678 · Cited by 32
Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways
Mikami, D., Kobayashi, M., Uwada, J., Yazawa, T., Kamiyama, K., Nishimori, K., Nishikawa, Y., Nishikawa, S., Yokoi, S., Kimura, H., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158666 · Cited by 30
Effects of Probiotic Supplementation on Exercise and the Underlying Mechanisms
Zhang, L., Zhang, R., & Li, L. (2023) · Foods · doi:10.3390/foods12091787 · Cited by 31
Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension
Vallianou, N. G., Kounatidis, D. C., Panagopoulos, F., Evangelopoulos, A. A., Stamatopoulos, V., Papagiorgos, A., Geladari, E. V., & Dalamaga, Μ. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01263-3 · Cited by 30
Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics
Ghahfarrokhi, S. S. M., Mohamadzadeh, M., Samadi, N., Fazeli, M. R., Khaki, S., Khameneh, B., & Bagheri, R. K. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00531-1 · Cited by 29
Zhang, H., Wang, J., Shen, J., Chen, S., Yuan, H., Zhang, X., Liu, X., Yu, Y., Li, X., Gao, Z., et al. (2024) · iMeta · doi:10.1002/imt2.220 · Cited by 31
Metadata
- Authors
- Marques, F. Z., Nelson, E., Chu, P.-Y., Horlock, D., Fiedler, A., Ziemann, M., Tan, J. K., Kuruppu, S., Rajapakse, N. W., El-Osta, A., Mackay, C. R., & Kaye, D. M.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- From Heart Failure Research Group (F.Z.M., E.N., P.-Y.C., D.H., A.F., N.W.R., D.M.K.) and Human Epigenetics Group (M.Z., A.E.-O.), Baker Heart and Diabetes Institute, Melbourne, Australia; Central Clinical School, Faculty of Medicine Nursing and Health Sciences (F.Z.M., A.E.-O., D.M.K.), Infection and Immunity Program, Monash Biomedicine Discovery Institute (J.K.T., C.R.M.), Department of Biochemistry and Molecular Biology (J.K.T., S.K., C.R.M.), and Department of Physiology (N.W.R.), Monash...
- ORCID
- Venue
- Circulation
- Published
- 2017-03-07
- Volume
- 135
- Issue
- 10
- Pages
- 964-977
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2560340862
- Cited by
- 1,065
- References
- 47
- Citations by year
- 2026: 95 · 2025: 142 · 2024: 137 · 2023: 136 · 2022: 148 · 2021: 144 · 2020: 101 · 2019: 77 · 2018: 56 · 2017: 29
- FWCI
- 28.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Diabetes Australia Research Trust
- Diabetes Australia
- State Government of Victoria
- Baker Heart and Diabetes Institute
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- high-fiber diet, acetate supplementation, gut microbiota, hypertension, heart failure, mineralocorticoid excess, Bacteroides acidifaciens, Firmicutes/Bacteroidetes ratio, myocardial fibrosis, left ventricular hypertrophy, renal fibrosis, EGR1, circadian rhythm, renin-angiotensin system, MAPK signaling, short-chain fatty acids, cardiovascular disease prevention
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Blood Pressure, Dietary Fiber, Disease Models, Animal, Fibrosis, Hypertension, Kidney, Male, Mice, Inbred C57BL, Myocardium, Organ Size, RNA, Ribosomal, 16S, Dietary Supplements, Principal Component Analysis, Gastrointestinal Tract, Mice, Transcriptome, Desoxycorticosterone Acetate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
